Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chiauranib plus Chidamide in R/R Non-Hodgkin's Lymphoma
NCT03974243Phase 2Completed
- Sponsor
- Akeso, Inc.
- Start
- Jul 2019
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of chiauranib in non-Hodgkin lymphoma (NHL), sponsored by Akeso, Inc.. Started Jul 2019; status: completed.
02
Drugs
chiauranib
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT03974243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03974243.